Comparison of Interleukin-33 Serum Levels in Patients with Breast Cancer and Idiopathic Granulomatous Mastitis.
Marzieh HaghbinAbdolreza Sotoodeh JahromiReza RanjbaranMojdeh AbbasiAkbar Hashemi TayerPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
IL-33 can be considered a significant factor distinguishing IGM and BC patients from controls, although it cannot be applied to diagnose and differentiate BC from IGM patients.<br />.